These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36566579)

  • 1. Vaccination against SARS-CoV-2 and risk of hospital admission and death among infected cancer patients: A population-based study in northern Italy.
    Gobbato M; Clagnan E; Toffolutti F; Del Zotto S; Burba I; Tosolini F; Polimeni J; Serraino D; Taborelli M
    Cancer Epidemiol; 2023 Feb; 82():102318. PubMed ID: 36566579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients.
    Whittaker R; Bråthen Kristofferson A; Valcarcel Salamanca B; Seppälä E; Golestani K; Kvåle R; Watle SV; Buanes EA
    Clin Microbiol Infect; 2022 Jun; 28(6):871-878. PubMed ID: 35219807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents.
    España PP; Bilbao-González A; Larrea N; Castillo-Sintes I; García-Gutiérrez S; Portuondo J; Villanueva A; Uranga A; Legarreta MJ; Gascon M; Quintana JM;
    Aging Clin Exp Res; 2023 Aug; 35(8):1771-1778. PubMed ID: 37249860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.
    Gong IY; Vijenthira A; Powis M; Calzavara A; Patrikar A; Sutradhar R; Hicks LK; Wilton D; Singh S; Krzyzanowska MK; Cheung MC
    JAMA Oncol; 2023 Mar; 9(3):386-394. PubMed ID: 36580318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SARS-CoV-2 vaccination on the severity of COVID-19 infection in patients on chronic dialysis.
    Miao J; Olson E; Houlihan S; Kattah A; Dillon J; Zoghby Z
    J Nephrol; 2023 Jun; 36(5):1321-1328. PubMed ID: 37017924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy.
    Lombardi A; Villa S; Colaneri M; Scaglione G; Bai F; Varisco B; Bono V; Vena A; Dentone C; Russo C; Tettamanti M; Renisi G; Viero G; Azzarà C; Mantero M; Peyvandi F; Bassetti M; Marchetti G; Muscatello A; Nobili A; Gori A; Bandera A;
    J Infect Public Health; 2024 Mar; 17(3):467-473. PubMed ID: 38262085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.
    Muhsen K; Maimon N; Mizrahi AY; Varticovschi B; Bodenheimer O; Cohen D; Dagan R
    JAMA Netw Open; 2022 Jul; 5(7):e2219940. PubMed ID: 35796153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 vaccination and risk of infectious diseases in hospitalized older patients.
    Balducci M; Locatelli E; Barbieri MG; Ferrighi E; Scardina S; Barrile G; Sganga F; Mattioli I; Remelli F; Maggi S; Volpato S; Trevisan C
    Eur Geriatr Med; 2024 Apr; 15(2):509-517. PubMed ID: 38182805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death.
    Russo AG; Faccini M; Decarli A; Cattaneo S; Tunesi S; Murtas R; Fagandini F; Bergamaschi W
    Epidemiol Prev; 2022; 46(5-6):324-332. PubMed ID: 36341584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older.
    Hosseini-Moghaddam SM; He S; Calzavara A; Campitelli MA; Kwong JC
    JAMA Netw Open; 2022 Sep; 5(9):e2233730. PubMed ID: 36169955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    Semenzato L; Botton J; Baricault B; Deloumeaux J; Joachim C; Sylvestre E; Dray-Spira R; Weill A; Zureik M
    PLoS One; 2022; 17(9):e0274309. PubMed ID: 36084113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    Efe C; Taşçılar K; Gerussi A; Bolis F; Lammert C; Ebik B; Stättermayer AF; Cengiz M; Gökçe DT; Cristoferi L; Peralta M; Massoumi H; Montes P; Cerda E; Rigamonti C; Yapalı S; Adali G; Çalışkan AR; Balaban Y; Eren F; Eşkazan T; Barutçu S; Lytvyak E; Zazueta GM; Kayhan MA; Heurgue-Berlot A; De Martin E; Yavuz A; Bıyık M; Narro GC; Duman S; Hernandez N; Gatselis NK; Aguirre J; Idilman R; Silva M; Mendizabal M; Atay K; Güzelbulut F; Dhanasekaran R; Montano-Loza AJ; Dalekos GN; Ridruejo E; Invernizzi P; Wahlin S
    J Autoimmun; 2022 Oct; 132():102906. PubMed ID: 36088883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy.
    Serraino D; Zucchetto A; Dal Maso L; Del Zotto S; Taboga F; Clagnan E; Fratino L; Tosolini F; Burba I
    Cancer Med; 2021 Nov; 10(21):7781-7792. PubMed ID: 34551210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.
    Mateo-Urdiales A; Spila Alegiani S; Fabiani M; Pezzotti P; Filia A; Massari M; Riccardo F; Tallon M; Proietti V; Del Manso M; Puopolo M; Spuri M; Morciano C; D'Ancona FP; Da Cas R; Battilomo S; Bella A; Menniti-Ippolito F; ;
    Euro Surveill; 2021 Jun; 26(25):. PubMed ID: 34169819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    Bakasis AD; Mavragani CP; Voulgari PV; Gerolymatou N; Argyropoulou OD; Vlachoyiannopoulos PG; Skopouli FN; Tzioufas AG; Moutsopoulos HM
    J Autoimmun; 2022 Jul; 131():102846. PubMed ID: 35717727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of covid-19 vaccination on hospitalization in a third-level hospital.].
    Haro Pérez AM; Benito López VE; Jiménez Rodríguez M; García Yu IA; Martín Monteagudo S
    Rev Esp Salud Publica; 2022 Feb; 96():. PubMed ID: 35194012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy).
    Consonni D; Lombardi A; Mangioni D; Bono P; Oggioni M; Uceda Renteria S; Valzano A; Bordini L; Nava CD; Tiwana N; Gentiloni Silverj F; Castaldi S; Rognoni M; Cavalieri D'Oro L; Carugno M; Luisetti G; Riboldi L; Ceriotti F; Bandera A; Gori A; Pesatori AC
    Epidemiol Prev; 2022; 46(4):250-258. PubMed ID: 36259341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
    Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
    BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.